U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Bizarre Patents

Patent No. 5823386

Reward Candy Dispenser for Personal Computers

A personal computer peripheral, battery powered reward candy dispenser which immediately presents students with a single candy for each problem completed correctly.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 424/501 - Contains solid synthetic resin


Subclass of Class 424 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the particles are impregnated with
No. of applications: 271
Last issue date: 05/24/2012


1              
Application No.Application TitleIssue Date
20120128783Compositions and methods for delivery of frozen particle adhesives
Certain embodiments disclosed herein relate to compositions, methods, devices, systems, and products regarding frozen particles. In certain embodiments, the frozen particles include materials at low temperatures. In certain embodiments, the frozen particles provide vehi...
05/24/2012
20120107408PHARMACEUTICAL MICROPARTICLES
Microparticles consisting of (a) a matrix with a mixture of (a1) at least one hydrophobic, biologically degradable polymer and (a2) optionally at least one water-soluble polymer, (b) a pharmaceutical active ingredient distributed in the matrix, and (c) in addition at le...
05/03/2012
20120082733METHODS FOR PROCESSING MICROSPHERES, MICROSPHERES PROCESSED THEREBY, AND USES THEREOF
The invention provides a manufacturing method for processing polymeric microspheres which are suspended in a liquid. The invention also provides polymeric microspheres produced by the method which can be used in medical settings as tissue fillers, tissue bulking agents,...
04/05/2012
20120045493Solid Cosmetic Composition with Structurant and Electrolyte Solution
A water soluble cosmetic or pharmaceutical or pharmaceutical actives in an electrolyte solution which, when impregnated with one or more retentive fillers (such as, for example, silica or hydrophobically modified silica, lamellar filler, crosspolymer, cellulosic, resins...
02/23/2012
20120040011ALKYNES AND METHODS OF REACTING ALKYNES WITH 1,3-DIPOLE-FUNCTIONAL COMPOUNDS
1,3-Dipole-functional compounds (e.g., azide functional compounds) can be reacted with certain alkynes in a cyclization reaction to form heterocyclic compounds. Useful alkynes (e.g., strained, cyclic alkynes) and methods of making such alkynes are also disclosed. The re...
02/16/2012
20120003322PH-SENSITIVE DENDRITIC POLYMERIC MICELLES
The present invention relates to a pH-sensitive PIC (polyion complex) type polymeric micelle formed by electrostatic interaction between a dendritic block copolymer and another polymer of opposite charge. The presence of a dendritic block copolymer confers high stabilit...
01/05/2012
20110311626CONTROLLED RELEASE COMPOSITIONS COMPRISING ANTI-CHOLINERGIC DRUGS
The present invention provides compositions comprising dicyclomine, or salts, and/or solvates and methods of making and using the compositions to treat intestinal hypermotility or Irritable Bowel Syndrome (IBS). The present invention also provides once-a-day orally disi...
12/22/2011
20110293701MULTIVALENT SYNTHETIC NANOCARRIER VACCINES
The invention relates, at least in part, to compositions comprising populations of synthetic nanocarriers that comprise different sets of antigens as well as related methods....
12/01/2011
20110287105Composition comprising biodegradable polymers for use in a cosmetic composition
The present invention relates to certain novel polymer powder compositions suitable for personal care and cosmetic compositions. The present invention also relates to cosmetic compositions comprising such novel polymer powders. The present invention also relates to proc...
11/24/2011
20110287085LIPOSOMAL CURCUMIN FOR TREATMENT OF CANCER
The present invention provides a compositions and methods for the treatment of cancer, including pancreatic cancer, breast cancer and melanoma, in a human patient. The methods and compositions of the present invention employ curcumin or a curcumin analogue encapsulated ...
11/24/2011
20110280948COMPOSITIONS AND METHODS FOR SEPARATING, CHARACTERIZING AND ADMINISTERING SOLUBLE SELENOGLYCOPROTEINS
The invention relates to soluble selenium compositions and methods of production, separation and purification thereof. In particular the present invention provides methods of preparing water soluble selenoglycoproteins (e.g., via extracting selenoglycoproteins from sele...
11/17/2011
20110280947Embolization
A particle includes a ferromagnetic material, a radiopaque material, and/or an MRI-visible material....
11/17/2011
20110280949MICROPARTICLES FOR USE IN IMMUNOGENIC COMPOSITIONS
Immunogenic compositions are disclosed which comprise microparticles that comprise a biodegradable polymer, an immunological adjuvant and a tocol-family compound. Methods of making and using such microparticle compositions are also disclosed....
11/17/2011
20110244049COMPOSITIONS COMPRISING 4-(2-(5-BROMO-4-(1-CYCLOPROPYLNAPHTHALEN-4-YL)-4H-1,2,4-TRIAZOL-3-YLTHIO)ACETAMIDO)-3-CHLOROBENZOIC ACID AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, AND METHODS FOR PREPARING AND USING SAME
The present invention relates to compositions comprising 4-(2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetamido)-3-chlorobenzoic acid or pharmaceutically acceptable salts thereof, and to the preparation and use of such compositions, in partic...
10/06/2011
20110217384Modified Release Dosage Forms of Skeletal Muscle Relaxants
A unit dosage form, such as a capsule or the like, for delivering a skeletal muscle relaxant, such as cyclobenzaprine hydrochloride, into the body in an extended or sustained release fashion comprising one or more populations of drug-containing particles (beads, pellets...
09/08/2011
20110206773SUSTAINED DELIVERY OF DRUGS FROM BIODEGRADABLE POLYMERIC MICROPARTICLES
Biodegradable polymeric microparticle compositions containing one or more active agents, especially those useful for treating or preventing or one or more diseases or disorders of the eye, and methods of making and using thereof, are described. The microsphere compositi...
08/25/2011
20110165254Drug Delivery Using Fine Fiber Encapsulation
The disclosure generally relates to a method of producing a handleable wafer of medicament powder (for example, aspirin powder) by utilizing a restraining envelope of fine water-soluble fibers, which are, upon use, quickly dissolved by bodily fluids. Such wafer would qu...
07/07/2011
20110150971ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise...
06/23/2011
20110150969ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise...
06/23/2011
20110151015IMMUNOMODULATOR PARTICLES AND METHODS OF TREATING
A method of stimulating an immune response in a subject including administering a micrometer-sized particle coupled with an antigen to the subject, wherein increasing the aspect ratio of the micrometer-sized particle increases the immune response. A method of stimulatin...
06/23/2011
20110150970ABUSE RESISTANT DRUGS, METHOD OF USE AND METHOD OF MAKING
An abuse resistant oral pharmaceutical composition, comprising: a barrier layer, comprising a first polymer; a diffusion layer, comprising a second polymer, substantially covering the barrier layer, wherein the diffusion layer is bonded to the barrier layer and comprise...
06/23/2011
20110142952Pharmaceutical Compositions
This invention relates to crosslinked amine-containing polymers for binding compounds or ions, and more specifically relates to pharmaceutically acceptable compositions for binding compounds or ions that include crosslinked amine-containing polymers. The pharmaceuticall...
06/16/2011
20110142951MICELLES FOR INTRACELLULAR DELIVERY OF THERAPEUTIC AGENTS
Composition comprising a polymeric micelle and an associated polynucleotide....
06/16/2011
20110135744Nanoparticle Based Therapy for Dispersing Mucin
There are provided compositions and methods to disperse mucin and/or actin using nanoparticles wherein the average diameter of the nanoparticles is less than about 1000 nm....
06/09/2011
20110129541SUSPENSION DELIVERY SYSTEM FOR THE SUSTAINED AND CONTROLLED LOCAL RELEASE OF PHARMACEUTICALS
The invention relates to a novel suspension delivery system for the sustained and controlled release of pharmaceuticals. Methods of preparation and use are also disclosed....
06/02/2011
20110129540Polymer of acrylic or methacrylic type comprising alpha-tocopherol grafts
The present invention relates to a novel family of polymers of acrylic and/or methacrylic type, comprising alpha-tocopherol grafts, capable of forming nanoparticles in an aqueous medium at a neutral pH.

It also relates to the use of such na...

06/02/2011
20110111010Method and Composition for Burned Skin
The present invention is directed to the use of an agent selected from ethyl alcohol, isopropyl alcohol or a mixture thereof and a topically acceptable polymeric carrier in the preparation of a composition for the treatment of burns....
05/12/2011
20110097419Poly(Propargyl-L-Glutamate) and Derivatives Thereof
A process of the present invention is directed toward conducting highly selective, high yield post-polymerization reactions on polypeptides to prepare functionalized polypeptides. In certain embodiments, the polypeptides can be prepared by ring opening polymerization of...
04/28/2011
20110097420CEMENT PRODUCTS AND METHODS OF MAKING AND USING THE SAME
Disclosed are cement products, methods of forming cement using the cement product, and methods of using the cement product in orthopedic and dental applications. Generally, the disclosed cement product includes a first component comprising a polymerizable resin comprisi...
04/28/2011
20110091538POLYMER ADAPTED TO RELEASE BIOACTIVE AGENTS IN VIVO, PHARMACEUTICAL COMPOSITION AND METHOD OF PREPARATION THEREOF
The present invention provides a Monodisperse Polymer Particles (MPP) adapted to release alkoxy groups by means of a hydrolyser, such that Monodisperse Bioactive Polymer Particles (MBPP) are obtained in vivo. The MBPP are characterized by (a) at least one naturally occu...
04/21/2011
20110091564INJECTABLE HOLLOW TISSUE FILLER
The present invention comprises a plurality of injectable hollow particulate fillers suspended in a biocompatible fluid carrier to significantly improve the clumping resistance and injectability of the composition. The hollow particulate fillers have a lower effective d...
04/21/2011
20110091566CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS
The present application discloses a sustained release composition in pellet form, wherein the core of the pellet comprises: (a) a therapeutically effective amount of a medicament; (b) 0.5 to 50% by weight of a water-soluble polymer; and (c) 25% by weight of a water-inso...
04/21/2011
20110081422PROLONGED RELEASE OF LOCAL ANESTHETICS USING MICROPARTICLES AND SURGERY APPLICATIONS
Methods and compositions for providing long term pain relief in, for example, surgery recovery, including injecting a composition comprising a plurality of microparticles having different sizes and at least one local anesthetic loaded into the microparticles at differen...
04/07/2011
20110081413Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Discl...
04/07/2011
20110064820Pharmaceutical Compositions Comprising Phosphate-Binding Polymer
The present invention discloses pharmaceutical composition comprising phosphate binding polymers such as Sevelamer carbonate substantially free of monovalent anion other than bicarbonate anion. Particularly, monovalent anion content is less than about 0.05% (w/w). Discl...
03/17/2011
20110064821ENCAPSULATION OF BIOLOGICALLY ACTIVE AGENTS
The present invention provides methods of encapsulating biologically active agents such as proteins in particulate carriers such as nanoparticles. Also provided are methods of delivery of proteins across the blood brain barrier in nanoparticles, and uses of such composi...
03/17/2011
20110059183WATER-INSOLUBLE MEDICINE
A method of producing water-insoluble anti-cancer drug in the form of particulates, the method including preparing a water-insoluble anti-cancer drug having at least one multiple bond in the structure, and irradiating said water-insoluble anti-cancer drug with a laser b...
03/10/2011
20110052652Solid pharmaceutical composition comprising agglomerated nanoparticles and a process for producing the same
The present invention relates to pharmaceutical compositions comprising at least one active ingredient delivered by a nanoparticle. More specifically, the invention relates to solid pharmaceutical compositions comprising nanoparticles, wherein the nanoparticles are in t...
03/03/2011
20110054375Dressing comprising polyacrylate particles and use thereof
The invention relates to dressings comprising a particle mixture of polyacrylate particles for using in modern wound treatment. The invention especially relates to a dressing comprising a particle mixture of polyacrylate particles, which contains a particle fraction for...
03/03/2011
20110052717SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES
Pharmaceutical composition made of microparticles for the slow release of an active substance at least during a period covering the 6th month after injection of said composition, said composition comprising a group of microparticles made of a copolymer of the PLGA type ...
03/03/2011
1              
 
Sign InRegister
Username  
Password   
forgot password?